Global Cell Line Generation Market Research Report 2022

Global Cell Line Generation Market Research Report 2022

Market Analysis and Insights: Global Cell Line Generation Market
The global Cell Line Generation market size is projected to reach US$ 3,184.5 million by 2028, from US$ 1,678.4 million in 2021, at a CAGR of 9.95% during 2022-2028.
Fully considering the economic change by this health crisis, Knockout Cell Lines accounting for 49.39% of the Cell Line Generation global market in 2021, is projected to value US$ 1,711.7 million by 2028, growing at a revised 22.55% CAGR in the post-COVID-19 period. While Pharmaceutical Industry segment is altered to an 10.19% CAGR throughout this forecast period.
China Cell Line Generation market size is valued at US$ 102.1 million in 2021, while the North America and Europe Cell Line Generation are US$ 560.7 million and US$ 619.1 million, severally. The proportion of the North America is 33.41% in 2021, while China and Europe are 6.08% and 36.89% respectively, and it is predicted that China proportion will reach 11.30% in 2028, trailing a CAGR of 21.48% through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR 12.32%, 8.46%, and 8.52% respectively for the next 6-year period. As for the Europe Cell Line Generation landscape, Germany is projected to reach US$ 234.7 million by 2028 trailing a CAGR of 7.89% over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Line Generation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Line Generation market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Line Generation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Line Generation market.
Global Cell Line Generation Scope and Market Size
Cell Line Generation market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Line Generation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company
Boehringer Ingelheim BioXcellence
Lonza
WuXi Biologics
Thermo Fisher Scientific
Sartorius
Merck
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Porton Biologics
Chempartner Pharmatech
Rentschler Biopharma
ProBioGen
AGC Biologics
OPM Biosciences
Charles River Laboratories
Mycenax Biotech
JOINN Laboratories

Segment by Type
Knockout Cell Lines
Overexpression Cell Lines
Inducible Expression Cell Lines
Knockdown Cell Lines
Knockin Cell Lines
Others

Segment by Application
Pharmaceutical Industry
Biological Industry
Others

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia

Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe

South America
Mexico
Brazil
Rest of Latin America

Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA